|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Eliem Therapeutics (NASDAQ: ELYM) through any online brokerage.
There are no as such competitors for Eliem Therapeutics.
The latest price target for Eliem Therapeutics (NASDAQ: ELYM) was reported by Guggenheim on September 7, 2021. The analyst firm set a price target for 32.00 expecting ELYM to rise to within 12 months (a possible 72.79% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Eliem Therapeutics (NASDAQ: ELYM) is $18.52 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Eliem Therapeutics.
Eliem Therapeutics’s $Q3 earnings are confirmed for after-market on $December 13, 2021.
There is no upcoming split for Eliem Therapeutics.
Eliem Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.